Lemaitre Vascular (LMAT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2012 | 12-2011 | 09-2011 | 06-2011 | 03-2011 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 386 | 2,143 | 1,797 | 583 | 64 |
| Depreciation Amortization | 548 | 2,037 | 1,466 | 950 | 461 |
| Income taxes - deferred | 4 | 1,159 | N/A | N/A | N/A |
| Accounts receivable | -87 | -174 | -422 | -388 | -768 |
| Other Working Capital | -1,507 | -4,237 | -1,402 | -2,251 | -4,143 |
| Other Operating Activity | 1,042 | 2,242 | 2,034 | 2,204 | 1,972 |
| Operating Cash Flow | $386 | $3,170 | $3,473 | $1,098 | $-2,414 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -271 | -2,021 | -1,404 | -754 | -515 |
| Net Acquisitions | 4 | 263 | 770 | -533 | -265 |
| Purchase Sale Intangibles | -45 | -64 | -47 | -26 | -19 |
| Other Investing Activity | -45 | -64 | -47 | -26 | -19 |
| Investing Cash Flow | $-312 | $-1,822 | $-681 | $-1,313 | $-799 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | 69 | 64 | 53 | 16 |
| Common Stock Repurchased | -602 | -2,213 | -1,459 | -522 | -376 |
| Dividend Paid | N/A | -1,237 | -929 | -619 | N/A |
| Other Financing Activity | 0 | -419 | 0 | 0 | 0 |
| Financing Cash Flow | $-602 | $-3,800 | $-2,324 | $-1,088 | $-360 |
| Exchange Rate Effect | 18 | -30 | 5 | 94 | 62 |
| Beginning Cash Position | 20,132 | 22,614 | 22,614 | 22,614 | 22,614 |
| End Cash Position | 19,622 | 20,132 | 23,087 | 21,405 | 19,103 |
| Net Cash Flow | $-510 | $-2,482 | $473 | $-1,209 | $-3,511 |
| Free Cash Flow | |||||
| Operating Cash Flow | 386 | 3,170 | 3,473 | 1,098 | -2,414 |
| Capital Expenditure | -271 | -2,021 | -1,404 | -754 | -515 |
| Free Cash Flow | 115 | 1,149 | 2,069 | 344 | -2,929 |